Aprea Therapeutics Inc. (NASDAQ: APRE)
$3.93
-0.1800 ( -4.38% ) 4.1K
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Market Data
Open
$3.93
Previous close
$4.11
Volume
4.1K
Market cap
$21.29M
Day range
$3.90 - $4.20
52 week range
$2.83 - $8.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 14, 2024 |
4 | Insider transactions | 1 | Mar 14, 2024 |
4 | Insider transactions | 1 | Mar 14, 2024 |
8-k | 8K-related | 22 | Mar 12, 2024 |
8-k | 8K-related | 50 | Feb 06, 2024 |
8-k | 8K-related | 14 | Feb 02, 2024 |
8-k | 8K-related | 12 | Jan 26, 2024 |
8-k | 8K-related | 49 | Jan 04, 2024 |
8-k | 8K-related | 49 | Nov 09, 2023 |
10-q | Quarterly Reports | 48 | Nov 09, 2023 |